Amphetamine psychosis: behavioral and biochemical aspects

J Psychiatr Res. 1974:11:13-23. doi: 10.1016/0022-3956(74)90064-8.
No abstract available

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Affect
  • Alcoholism / cerebrospinal fluid
  • Amphetamine / antagonists & inhibitors
  • Amphetamine / pharmacology*
  • Brain / metabolism*
  • Cognition Disorders / chemically induced
  • Delusions / chemically induced
  • Depression / chemically induced
  • Dextroamphetamine / pharmacology
  • Dihydroxyphenylalanine / pharmacology
  • Dopamine / metabolism*
  • Dose-Response Relationship, Drug
  • Ethylene Glycols / cerebrospinal fluid
  • Hallucinations / chemically induced
  • Haloperidol / therapeutic use
  • Homovanillic Acid / cerebrospinal fluid
  • Humans
  • Male
  • Methoxyhydroxyphenylglycol / cerebrospinal fluid
  • Psychoses, Substance-Induced / drug therapy
  • Psychoses, Substance-Induced / metabolism*
  • Receptors, Drug*
  • Schizophrenia / cerebrospinal fluid
  • Schizophrenia / metabolism*
  • Schizophrenic Language
  • Schizophrenic Psychology
  • Stereoisomerism

Substances

  • Ethylene Glycols
  • Receptors, Drug
  • Methoxyhydroxyphenylglycol
  • Dihydroxyphenylalanine
  • Amphetamine
  • Haloperidol
  • Dextroamphetamine
  • Dopamine
  • Homovanillic Acid